Skip to main content
Larkosis Pharma Logo
Glycopyrrolate Injection

Category

Anticholinergic

Form

Injection

Strength

0.2mg/ml

CAS

596-51-0

Glycopyrrolate Injection 0.2mg/ml – Advanced Anticholinergic Therapy

Effective secretion control and cardiac stabilization. Supports anesthesia and surgical procedures. Rapid onset with controlled pharmacological action. Used in emergency and ICU settings. Manufactured under global pharmaceutical standards.

Glycopyrrolate Injection 0.2mg/ml (CAS No: 596-51-0) by LARKSOIS Pharma is a high-quality injectable formulation. Designed for use in anesthesia, emergency medicine, and ICU care. Reduces parasympathetic activity without significant CNS penetration. Ensures effective secretion control and cardiovascular stability. Manufactured under strict international standards.

Request Quote

Overview

  • Glycopyrrolate Injection 0.2mg/ml is a potent anticholinergic agent.
  • Used to control excessive secretions and stabilize heart rate.
  • Provides rapid and predictable therapeutic response.
  • Widely used in perioperative and critical care.
  • Ensures reliable clinical outcomes.

Introduction

  • Glycopyrrolate Injection 0.2mg/ml (CAS No: 596-51-0) by LARKSOIS Pharma is a high-quality injectable formulation.
  • Designed for use in anesthesia, emergency medicine, and ICU care.
  • Reduces parasympathetic activity without significant CNS penetration.
  • Ensures effective secretion control and cardiovascular stability.
  • Manufactured under strict international standards.

Important Information

  • Anticholinergic agent used in surgical and emergency settings.
  • Reduces salivary, bronchial, and tracheal secretions.
  • Prevents vagal reflexes and bradycardia.
  • Requires medical supervision.
  • Essential in anesthesia and critical care.

Dosage

General

  • Adults: 0.1–0.2 mg IV/IM as required
  • Pediatric: Dose based on body weight
  • Adjust dosage based on clinical condition

Administration

  • Administer intravenously or intramuscularly
  • Slow IV administration preferred
  • Use aseptic technique
  • Monitor vital signs continuously

Important

  • Use only under medical supervision
  • Avoid overdose
  • Monitor heart rate and patient response

Storage

  • Store below 25°C
  • Protect from direct light
  • Do not freeze
  • Keep in original packaging
  • Use immediately after opening

Shelf Life

  • Shelf life: 24–36 months
  • Check expiry before use
  • Discard unused portion after opening

Manufacturing

  • Manufactured in WHO-GMP certified facilities
  • Sterile injectable production environment
  • High-purity API (CAS 596-51-0)
  • Multi-stage filtration and sterilization
  • Complies with global regulatory standards

Precautions

  • Use cautiously in patients with glaucoma
  • Avoid in severe ulcerative colitis
  • Monitor patients with cardiac conditions
  • Use carefully in elderly patients
  • Maintain hydration
  • Avoid overdose due to anticholinergic effects

Side Effects

  • Dry mouth
  • Blurred vision
  • Tachycardia
  • Urinary retention
  • Constipation
  • Reduced sweating
  • Confusion (rare)
  • Severe allergic reactions (rare)

Expert View

  • Highly effective anticholinergic therapy.
  • Essential in anesthesia and surgical care.
  • Provides reliable cardiovascular stabilization.
  • Widely used in ICU and emergency medicine.
  • Consistent and predictable pharmacological response.

Indications

  • Preoperative reduction of secretions
  • Prevention of bradycardia during surgery
  • Adjunct to anesthesia
  • Reversal of neuromuscular blockade
  • Management of symptomatic bradycardia
  • Control of excessive drooling

Maintenance

  • Use under controlled clinical settings
  • Monitor patient vitals continuously
  • Adjust dose based on response
  • Follow physician guidance strictly
  • Ensure proper follow-up care

Why Choose

  • Precise anticholinergic action
  • Effective secretion control
  • Reliable cardiovascular support
  • Sterile high-quality formulation
  • WHO-GMP certified manufacturing
  • Globally trusted quality

Frequently Asked Questions

Common product and supply questions.

What is a glycopyrrolate injection used for?+

Glycopyrrolate Injection is used to reduce excessive secretions, support anesthesia, and manage bradycardia in surgical and emergency settings.

How to give IV glycopyrrolate?+

It should be administered slowly intravenously by a trained healthcare professional with continuous monitoring of vital signs.

Is glycopyrrolate used for bradycardia?+

Yes, it increases heart rate by blocking vagal activity and is used in emergency and perioperative care.

Is glycopyrrolate injection safe for everyone?+

It is generally safe but requires caution in patients with glaucoma, cardiac disorders, or gastrointestinal conditions.

What are the serious side effects of glycopyrrolate?+

Serious side effects include tachycardia, urinary retention, confusion, and rare allergic reactions requiring medical attention.